HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


California DTSC Moving Hair-Straightening, Nail Product Ingredients, 1-4-Dioxane Through SCP Process

Executive Summary

Nail products containing toluene became the Safer Consumer Products program’s first Priority Product in the beauty and personal-care category in January 2023, triggering alternatives analysis requirements. More nail product chemicals are under evaluation by California’s Department of Toxic Substances Control, as well as hair-straightening chemicals and 1,4-dioxane.

You may also be interested in...

California DTSC Was ‘Unaware’ Of 40+ Hazardous Chemicals In Nail Care That May Get Closer Looks

The relatively small number of stakeholders who responded to DTSC’s information call-in revealed that the vast majority of nail products likely contain Candidate Chemicals on California DTSC’s authoritative lists. The department will continue to evaluate CCs in nail care for potential regulation by the Safer Consumer Products program.

California DTSC Begins Taking Notifications Of Nail Products Containing Toluene

Effective 1 January, Nail Products Containing Toluene are the latest Priority Product adopted under California’s Safer Consumer Products regulation, requiring notifications from responsible entities by 2 March or 60 days after affected products enter the market. Alternatives analysis work will follow for companies that do not reformulate or discontinue products, among other options.

Personal-Care Firms Filing Waiver Requests En Masse As 1,4-Dioxane Deadline Looms In New York

More than 800 waivers have been filed by companies including Procter & Gamble, L’Oréal and Coty with the first deadline fast-approaching for limiting 1,4-dioxane in personal-care products under a law enacted in New York in 2019.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts